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Mitochondria are involved in a number of diverse cellular functions, including energy production, metabolic regulation,
apoptosis, calcium homeostasis, cell proliferation, and motility, as well as free radical generation. Mitochondrial DNA
(mtDNA) is present at hundreds to thousands of copies per cell in a tissue-specific manner. mtDNA copy number also varies
during aging and disease progression and therefore might be considered as a biomarker that mirrors alterations within the
human body. Here, we present a new quantitative, highly sensitive droplet digital PCR (ddPCR) method, droplet digital mi-
tochondrial DNAmeasurement (ddMDM), to measure mtDNA copy number not only from cell populations but also from
single cells. Our developed assay can generate data in as little as 3 h, is optimized for 96-well plates, and also allows the direct
use of cell lysates without the need for DNA purification or nuclear reference genes. We show that ddMDM is able to detect
differences between samples whose mtDNA copy number was close enough as to be indistinguishable by other commonly
used mtDNA quantitation methods. By utilizing ddMDM, we show quantitative changes in mtDNA content per cell across a
wide variety of physiological contexts including cancer progression, cell cycle progression, human T cell activation, and
human aging.
[Supplemental material is available for this article.]
Humanmitochondrial DNA (mtDNA) is a circular 16.6-kb genome
residing within the mitochondrial matrix that encodes for 13 pro-
tein components of the electron transport chain essential for oxi-
dative phosphorylation (OXPHOS). mtDNA is present at hundreds
to thousands of copies per cell, varying widely between cell types
and tissues (Robin and Wong 1988; Pierce et al. 1990; Shay et al.
1990). Cellular coordination of mtDNA content is a dynamic
and tightly regulated process (Li et al. 2005; Scarpulla 2006; Wu
et al. 2006); however, the mechanisms by which mtDNA copy
number is monitored and controlled are not well understood
(Moraes 2001; Clay Montier et al. 2009; Klingbeil and Shapiro
2009). In addition, alterations in mtDNA levels often accom-
pany key pathophysiological changes during the transition from
healthy to diseased states (Butow and Avadhani 2004), and a num-
ber of age-related diseases correlate with mtDNA abundance, in-
cluding cardiovascular disease (Yue et al. 2018), type 2 diabetes
(Malik et al. 2009; Monickaraj et al. 2012), cancer (Afrifa et al.
2018), and dementia (Rice et al. 2014; Pyle et al. 2016). Further-
more, mtDNA levels in peripheral blood mononuclear cells
(PBMCs) gradually decrease during aging and are associated with
health status among the elderly (Mengel-From et al. 2014; Wach-
smuth et al. 2016), suggesting that mtDNA may be a biomarker
of biological (not chronological) age and disease exposure (Pieters
et al. 2015; Qiu et al. 2015; Tyrka et al. 2015).
The growing relevance of mtDNA as a biomarker highlights
the need for a more high-throughput method of mtDNA quantifi-
cation. The current standard employed in the measurement of
mtDNA copy number is quantitative PCR (qPCR). Measurements
by qPCR require the use of a reference gene and are often displayed
as a ratio of mitochondrial to nuclear DNA; however, qPCR is par-
ticularly susceptible to differing PCR efficiencies between target
and housekeeping genes, leading to skewing of this ratio (Regier
and Frey 2010; Kiselinova et al. 2014). Additionally, the use of a ref-
erence gene subjects qPCR results to compounding errors, further
reducing the sensitivity of qPCR measurement. Recent work has
strengthened the utility and flexibility of droplet digital PCR
(ddPCR) technology (Ludlow et al. 2014; Huang et al. 2017). The
ddPCR technology uses oil emulsion to partition samples into
thousands of droplets, each representing an independent PCR sys-
tem. Since all template-containing droplets reach plateau during
the PCR step, complications arising from PCR inhibitors and
differing PCR efficiencies are minimized. The total number of
droplets and droplets that fluoresce are counted in a flow cytome-
try-like fashion to produce a ratio that is then subjected to Poisson
distribution, resulting in an absolute quantification of starting
template molecules (Hindson et al. 2011; Pinheiro et al. 2012;
Robin et al. 2016). Methods to quantify mtDNA copy number by
ddPCR using purified genomic DNA have recently been developed
(Hindson et al. 2011; Pinheiro et al. 2012; Podlesniy et al. 2013;
Wachsmuth et al. 2016). However, the time-consuming nature
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of DNA purification represents a major rate-limiting step in the
quantification of nucleic acids (Van Peer et al. 2012) and thus ama-
jor hurdle in developing much needed higher-throughput meth-
ods for mtDNA copy number evaluation.
Here, we present a new quantitative, highly sensitive ddPCR
method, droplet digital mitochondrial DNA measurement
(ddMDM), to measure mtDNA content per cell equivalent directly
from cell lysates and in single cells without the need for DNA pu-
rification or inclusion of nuclear reference genes.
Results
ddMDM workflow and experimental design
We optimized the ddMDMworkflow for accuracy in quantitation,
reproducibility, speed, and higher-throughput applications (Fig.
1A). We initially created three sequences (amplicons) representing
the mtDNAD-Loop,MT-ND1, andMT-TL1 regions; wemade serial
dilutions of the amplicons and evaluated the linearity and slopes
of three different primer pairs targeting these sequences (Fig. 1B;
Supplemental Fig. 1A,B; Supplemental Tables S1, S5). We con-
firmed that measurements taken by using ddPCR accurately re-
flected absolute molecules per reaction in a nearly 1-to-1 ratio
(Fig. 1B; Supplemental Fig. 1A,B; Supplemental Tables S1, S5).
Because large mtDNA deletions encompassing the D-Loop
region have not been previously reported (Bai and Wong 2005),
the primer pair targeting the D-Loop region was employed in all
subsequent experiments.
Since the results by using serial dilutions of amplicons were
highly reproducible (Fig. 1B; Supplemental Table S1), we next
evaluated the reproducibility of the assay when cell lysates rather
than artificial amplicons are used. To this aim, we evaluated the
intra- and the inter-assay variability by measuring the coeffi-
cients of variation (CV) across twofold dilution series of BJ fibro-
blasts cell lysates. We documented very robust reproducibility
across seven serial dilutions, with the best reproducibility seen
within the range of 800 to 1000 D-Loop molecules per reaction
(inter-assay CV=1.6%; intra-assay CV=2.5%) (Fig. 1C,D;
Supplemental Table S1). Consistent with other previously pub-
lished ddPCR methods (Ludlow et al. 2014), this corresponded
to ∼5% of fluorescent (positive) droplets out of the total number
of droplets.
We nextmeasured the limit of detection of ddMDMby quan-
tifying mtDNA in a 10-fold dilution series of cell lysates (stimulat-
ed T cells) and observed that ddMDMcan quantifymtDNA from as
little as one hundredth of a cell equivalent (R2 = 0.99) (Fig. 1E;
Supplemental Table S1). Finally, we tested in a dilution series of
cell lysates whether a hydrolysis probe approach (TaqMan) could
further improve the accuracy of ddMDMwhen compared to using
EvaGreen, but we observed no difference in mtDNA copy number
quantitation between the two fluorophores (Supplemental Fig. 1C;
Supplemental Table S5). For this reason, EvaGreen (less expensive
and simpler to use than TaqMan probes) was employed in all
experiments. Together, these results demonstrate that ddMDM
reliably quantitates mtDNA copy number by using cell lysates
directly. In addition, we quantitated differences in mtDNA
content between resting, stimulated, and transformed T cells
(Fig. 1F; Supplemental Table S1). Raw ddPCR output was then
transformed into absolute numbers of mtDNA molecules per cell
equivalentwith a high degree of precision (P< 0.001) (Fig. 1G; Sup-
plemental Table S1).
ddMDM is more sensitive compared to other commonly
employed techniques
Current techniques for assaying mtDNA copy number are often
limited in their ability to detect subtle changes in mtDNA levels.
As such, it is unknown at what threshold minor perturbations in
cellular mtDNA content begin to impact health and disease. We
therefore compared ddMDM’s limit of sensitivity to that of other
methods by calculating the smallest significant difference that
was detectible by each technique. To test this for other techniques,
we mixed mitochondrial and genomic amplicons in fixed ratios,
simulating samples that differed in mtDNA copy number by set
percentages (10% increments in mtDNA) compared to a baseline
control. Student’s t-test was used to compare each sample against
the baseline control and one-way ANOVA was employed to com-
pare each sample against every other sample. In addition, the stan-
dard error of the estimate (σest) was calculated as a measure of the
overall variability in each assay. We observed that qPCR could sig-
nificantly (P<0.05, Student’s t-test) distinguish between samples
whose mtDNA/nDNA copy number ratio differed by at least 50%
(Fig. 2A; Supplemental Table S2), whereas the more stringent
ANOVA showed that differences could only be detected at 60%
(P<0.05). The σest for qPCR detection was 21.3%, reflecting how
even moderate deviations in threshold cycles (Ct) can produce
large changes in relative abundance calculations.
In contrast, ddPCRcan detect significant differences (P<0.05,
Student’s t-test) as low as 30% above the baseline, with a σest of
13.1% (Fig. 2B; Supplemental Table S2). ANOVA showed that all
comparisons with >33% difference in sample loaded were signifi-
cant. The exact same DNA samples were used for both qPCR and
ddPCR experiments, emphasizing that ddPCR use of endpoint
rather than threshold fluorescence produces less variable results
and quantifications closely resembling the sample ratio that was
prepared (Pinheiro et al. 2012; Kiselinova et al. 2014; Zhao et al.
2016).
Finally, we tested the limit of sensitivity for ddMDM using a
dilution series of cell lysates from stimulated human T lympho-
cytes. We found that ddMDM was able to distinguish, with a
high degree of significance (P<0.001, Student’s t-test), all samples
from the baseline sample (Fig. 2C; Supplemental Table S2).
Furthermore, ANOVA showed that samples characterized by at
least a 9.1% difference inmtDNA content were significantly differ-
ent. Unlike standard qPCR and ddPCR assays, ddMDM foregoes
the use of a nuclear reference gene and thus eliminates the com-
pounded error caused by variability of an additional sample in cal-
culating copynumber. The advantage of this is further highlighted
by the σest of only 3.77% (Fig. 2C; Supplemental Table S2). In sum-
mary, we show that ddMDM can detect significant differences be-
tween sampleswhosemtDNA copynumberwas close enough as to
be indistinguishable by other established mtDNA quantitation
techniques.
Detection of mtDNA in a variety of human cells by ddMDM
In order to show the utility and flexibility of ddMDM,we evaluated
mtDNA content in various cell types and cellular contexts.
Initially, we examined differential abundance in mtDNA in nor-
mal and transformed human cells, having hundreds to thousands
of mtDNA copies per cell (Fig. 3A; Supplemental Table S3).
Consistent with previously reported studies, we interpret our re-
sults to suggest that mtDNA content varies widely depending on
both cell size and cell line-specific metabolic profiles (Robin and
Wong 1988; Veltri et al. 1990).
Quantification of mtDNA copy number
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Figure 1. Optimized workflow and validation of the method. (A) General workflow of ddMDM for the quantification of mtDNA on a per cell equivalent
basis using ddPCR. (B) Absolute quantification of D-Loop amplicons by ddPCR in a 10-fold dilution series. Axes are displayed in log10 scale. Error bars show
the standard deviation of four technical replicates. (C) Inter-assay variability of ddMDM. Data points represent the mean of means of four biological rep-
licates run in duplicate (seven separate dilution series of early passage BJ fibroblasts’ cell lysates). Adjacent numbers show the coefficient of variation (CV) of
the means. (D) Intra-assay variability of ddMDM. Data points represent the average of five technical replicates from a single twofold dilution series of early
passage BJ fibroblasts. (E) Limit of detection. Tenfold dilution series in late passage BJ fibroblasts. Data points show the average of two experiments run in
triplicate. Error bars display the standard deviation of the six replicates. (F ) ddPCR output showing resting and stimulated T lymphocytes, Jurkat T leukemia
cells, and a cell-free (lysis buffer) control. Each lane shows a single ddPCR well, containing an input of 5 cell equivalents. Dots represent emulsion droplets.
(G) Quantification of ddPCR results. mtDNA copy number was calculated per cell equivalent. Error bars show the standard deviation of biological replicates.
Significance was determined by ANOVA (Tukey’s multiple comparisons).
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Changes in mtDNA copy number during aging have been
shown to be tissue- and cell-type–specific (Wachsmuth et al.
2016). For example, mtDNA levels decrease in human peripheral
immune cells during aging (Mengel-From et al. 2014), but they
can increase in other cell types. For example, increases in mtDNA
content occur during in vitro replicative aging of humanbronchial
epithelial cells (HBECs) (Fig. 3B; Supplemental Table S3).
Consistently, the most significant increase in mtDNA copies per
cell occurred at around 3–4 population doublings (PD) prior to
replicative senescence (∼PD 42) (Fig. 3B; Supplemental Table S3)
and was accompanied by a decreased replicative capacity.
Metabolic reprograming is one of the key hallmarks of cancer
(Ward and Thompson 2012), and mtDNA copy number has been
reported to correlate with cancer invasiveness and overall patient
outcomes (Chen et al. 2016; Hu et al. 2016). In addition, it has
been suggested that lower levels of mtDNA in certain cancers
may reflect a more stem-like metabolic program and be important
in cancer stem cell biology (Lee et al. 2015; Menendez 2015). We
used the normal human colonic epithelial cells (HCEC) system
with experimentally introduced mutations that commonly occur
during colorectal cancer initiation and early progression to exam-
ine changes in mtDNA copy number (Eskiocak et al. 2011; Zhang
et al. 2015). Specifically, we employed ddMDM to assess how
mtDNA abundance varied in response to loss of tumor suppressors
(TP53 andAPC), oncogenicmutations (KRASv12), andTERT, CDK4,
andMYCoverexpression in normalHCECs.We found a significant
decrease in mtDNA per cell in the context of KRAS (1CTR and
1CTRPA) and KRAS+MYC (1CTRPM) overexpression (P<0.05
and P<0.01 respectively) (Fig. 3C; Supplemental Table S3), sug-
gesting that these cells may be reverting to a more stem-like, un-
differentiated state characterized by limited OXPHOS and a
preference toward glycolysis (Menendez 2015; Kawada et al. 2017).
ddMDM for quantitation of mtDNA copy number
in single cells
During disease progression, as well as normal aging, key cellular
subsets within amixed cell population often contribute in varying
and crucial ways. However, when these peculiar cell subsets are
rare, they become diluted and dispersed within the heterogeneous
population generally below detection (Mendenhall et al. 2016;
Ibrahim-Hashim et al. 2017). In cancer, for example, metabolic re-
programming within tumor subpopulations represents one pos-
sible molecular mechanism by which chemotherapy-induced
resistance can be acquired (Morandi and Indraccolo 2017). There-
fore, in order to further characterize diverse and metabolically dis-
tinct T cell subpopulations, efficient methods for measuring
mtDNA copy number at the single-cell level are needed.
Therefore, we next investigated whether ddMDM was sensi-
tive enough to reliably measure mtDNA copy number in single
cells. Starting with a clonal population, single H1299 human
lung cancer cells were plated in 1-µL aliquots onto glass slides
and visually confirmed for the presence of exactly one cell by mi-
croscopy. Each individual cell was then lysed in a separate tube and
0.3-cell equivalents were employed for the ddMDM assay. Due to
the exceptional sensitivity of ddMDM, less than a single-cell
equivalent was sufficient to provide an adequate ddPCR signal.
This allowed us to perform all single-cell ddMDM in triplicate
(from the same individual cell), providing technical replicates for
each single-cell reaction. We found that mtDNA content varied
widely from cell to cell (Fig. 3D; Supplemental Table S3). However,
the average mtDNA content from pooling the results from single
cells was nearly identical to that of the pooled mixed population
of cells (Fig. 3E; Supplemental Table S3). This suggests that these
results reflect extreme intercellular differences in mtDNA copy
number rather than some type of technical artifact. Additionally,
these large differences between single cells cannot be fully ex-
plained by cell cycle-dependent variations in mtDNA copy
A
B
C
Figure 2. Limit of sensitivity for ddMDM and other previously reported
techniques formtDNA detection. Data points are the result of two separate
experiments each performed in triplicate. Asterisks indicate significance by
Student’s t-test between each sample compared to the baseline control.
(∗∗) P<0.01, (∗∗∗) P<0.001. σest displays the standard error of the estimate
as a percentage, normalized to the populationmean. (A) qPCR determina-
tion of D-Loop/NCOA3 ratio using purified amplicons. (B) ddPCR determi-
nation of D-Loop/NCOA3 ratio of the exact same samples employed in
Figure 2A. (C) ddMDM determination of mtDNA molecules (D-Loop) per
cell equivalent (stimulated T cells).
Quantification of mtDNA copy number
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number (Supplemental Fig. 1D; Supplemental Table S5). Although
we observed a significant increase in mtDNA copy number during
the transition from G2 to M phase, and a significant decrease dur-
ing the early G1 phase, these changes were modest when com-
pared to single-cell mtDNA heterogeneity in cancer cells (Fig.
3D; Supplemental Fig. 1D; Supplemental Tables S3, S5). To inves-
tigate further whether the observed high intercellular variability
in mtDNA content was due to real biological differences between
single cells or was due to a limitation in our single-cell isolation
method, we seeded H1299 at clonal density and expanded several
clones. When clones reached approximately 2–3 ×105 cells (corre-
sponding to∼18 population doublings), we isolated single cells via
FACS and repeated the single-cell mtDNA quantification. We
found a consistently lower intercellular variability in mtDNA con-
tent in single cells sorted from the same clone (Supplemental Fig.
2; Supplemental Table S6) as compared to single cells from the
original heterogeneous population (Fig. 3D; Supplemental Table
S3). These data can be interpreted to suggest that the intercellular
heterogeneity initially observed can be explained, at least in part,
by the presence of varying cell subpopulations in cancer as
previously suggested (Januszyk et al. 2015). In summary, these re-
sults show that ddMDM can reliably quantify and detect differ-
ences in mtDNA content in single cells.
mtDNA levels during T cell stimulation decrease with age,
but healthy centenarians escape this decline
Previously, we identified genes and pathways potentially involved
in the process of healthy human immune cell aging and longevity
through the study of stimulated PBMCs from a well-characterized
population of 114 individuals aged 23–113 yr (Tedone et al.
2019). PBMCs are a heterogeneous cell populationmainly consist-
ing of T cells, a major component of human immune responses. T
cells remain in a resting or quiescent nonproliferating state when
unstimulated, retaining decreased cell size and lowermetabolic ac-
tivity. In contrast, upon antigen-specific activation, T cells rapidly
divide and exhibit significant changes in gene expression (Zhao
et al. 2014; Tedone et al. 2019) and metabolic features (Dimeloe
et al. 2017). Activated T cells initiate immune responses such as dis-
criminating between healthy and abnormal (e.g., infected or can-
cerous) cells in the body and thus represent a valuable model to
study the physiological function of the adaptive immune system.
Previous studies have shown a progressive decline of mtDNA
copy number in resting PBMCs during aging (Kim et al. 2013;
Mengel-From et al. 2014; Wachsmuth et al. 2016). However, com-
paring stimulated PBMCmtDNA levels in different age groups, in-
cluding centenarians (100+ yr old), is an understudied area of
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Figure 3. ddMDMquantification of mtDNA in different cell types. (A) Absolute mtDNAmolecules per cell equivalent were measured in different primary
and transformed cell lines. (B) mtDNA levels in primary HBECs at the indicated population doublings. (C) mtDNA levels in human colonic epithelial cell
(HCEC) cancer progression series. Error bars show the standard deviation of biological triplicates. (D) mtDNA from 73 single H1299 cells were quantified.
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of the 73 single cells.
O ’Hara et al.
1882 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on December 19, 2019 - Published by genome.cshlp.orgDownloaded from 
research and might provide new insights about the mechanisms
driving the age-related impairment of the immune system. Thus,
we stimulated PBMCs from 22 healthy adults (aged 33±7 yr; here-
after referred to as “young”), 22 elderly adults (aged 73±6 yr; here-
after referred to as “old”), and 17 centenarians (aged 104±4 yr) and
employed ddMDM to track changes in mtDNA levels over a 15-d
(Young) or 10-d (Old and Centenarian) period following stimula-
tion. Since centenarians’ health status has been reported to
strongly correlate with their immune cell replicative potential
and gene expression (Tedone et al. 2019), we subdivided our cente-
narians’ study group into two subgroups: healthier centenarians
and frail centenarians (Supplemental Table S7; Tedone et al. 2019).
Consistent with previous studies (Dimeloe et al. 2017;
D’Souza et al. 2007), upon stimulation, mtDNA levels were tran-
siently up-regulated, generally peaking 3–6 d after stimulation
and then slowly declining (Fig. 4A; Supplemental Table S4). A small
A
B
C D
Figure 4. mtDNA in T cells shows stimulation- and age-dependent changes. (A) T cells from 22 healthy donors (aged 33 ±7) were stimulated at day 0 by
anti-CD3/CD28 beads and mtDNA per cell equivalent was measured over a 15-d period of stimulation. Open circles represent individual mtDNA per cell
from each of the 22 individuals, while the line traces the average of all individuals at each day. (B) T cells from22 healthy young (aged 33 ±7), 22 healthy old
(aged 73 ±6), 7 healthy centenarian (aged 104 ±4), and 10 frail centenarian (aged 104 ±3) individuals were stimulated as described above. mtDNA was
measured over the course of the stimulation, and the highest point that mtDNA reached for each individual was designated as the “peak” mtDNA of that
individual’s stimulation. Shown are averages and standard deviation of the peak mtDNA of each age group. Significance was determined by one-way
ANOVA. (C)MT-ND4 and D-Loopmolecules were measured from T cells to show the prevalence of mutated mtDNA (carrying the 4977-bp common dele-
tion) to total mtDNA. Significance was determined by ANOVA (Tukey’s multiple comparisons). (D) The percentage of mtDNA carrying MT-ND4 deletion
was plotted versus age for all 61 study participants. Linear regressions were performed for young, old, and frail centenarians (gray line) and young, old, and
healthy centenarians (black line).
Quantification of mtDNA copy number
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but significant dip inmtDNAper cell can be seen at day 1 (422±44
vs. 298±85at days0 and1, respectively;P< 0.0001), possibly indic-
ative of activation-induced cell death occurring in a subset of cells
(Kabelitz et al. 1993). Unstimulated PBMCs (day 0) showed lower
levels of mtDNA, in line with these cells being in a quiescent state,
and no significant differences were detected between the study
groups (Fig. 4B; Supplemental Table S4). Althoughprevious studies
have reported decreased mtDNA in blood during aging (Kim et al.
2013; Mengel-From et al. 2014;Wachsmuth et al. 2016), our study
found no significant differences. While we measured mtDNA in
resting PBMCs (mostly T cells) cultured in vitro, most previous
studies employed DNA isolated from whole blood. In blood, there
are free-circulating mtDNA molecules, granulocytes (not part of
PBMCs), and both red blood cells and platelets (that contain
mtDNA but no genomic DNA), suggesting that the ratio mtDNA/
nDNA inwhole blood could be different compared to PBMCs alone
(Hurtado-Roca et al. 2016). Another possibility is that the em-
ployed culture conditions (cells were kept in culture for at least
24 h before stimulation) slightly altered the cell physiological
mtDNA copy number of resting PBMCs.
However, during stimulation a noticeable impairment in
mtDNA biogenesis can be seen with increased age, as measured
by the mtDNA copy number peak of each individual over the
course of the stimulation period (809±332 vs. 1528±272 in old
vs. young, respectively; P<10−8) (Fig. 4B; Supplemental Table S4).
This suggests an age-related impairment in PBMCs’ ability to up-
regulate mtDNA biogenesis in response to antigen-specific activa-
tion. However, we found that the mtDNA copy number peak was
significantly higher in healthy centenarians as compared to old
(aged 73±6; 1198±261 vs. 809±332; P<0.05) (Fig. 4B; Supple-
mental Table S4). Given the importance of this data, we further
confirmed the mtDNA copy number in stimulated PBMCs from
healthy and frail centenarians by repeating mtDNA quantitation
using the other previously validated sets of primers amplifying
theMT-ND1 andMT-TL1 regions (Supplemental Fig. 1A,B; Supple-
mental Table S5). We found a very significant correlation between
mtDNA quantitation using D-Loop primers and mtDNA quantita-
tion using both MT-ND1 and MT-TL1 primers (Supplemental Fig.
1E,F; Supplemental Table S5). Overall, these data support the idea
that mtDNA biogenesis during immune cell stimulation may be a
potential biomarker of healthy aging.
ddMDM to quantify common mtDNA deletions: a pilot
study in centenarians
Over the course of an individual’s lifespan, mtDNA mutations and
deletionsaccumulatewithincells andtissues; insomeinstances,mu-
tantmtDNApropagatesatanevenfaster rate thanitswild-typecoun-
terparts (Trifunovic et al. 2004; Lakshmanan et al. 2018). It has been
suggested that such age-related increases in mtDNA heteroplasmy
may contribute to the onset and progression of various diseases
(Cortopassi et al. 1992; Chen et al. 2011). The most frequent
mtDNA mutation is the “mtDNA common deletion,” a 4977-bp
deletion occurring between two 13-bp direct repeats, resulting in
the disruption of mitochondrial complexes I, IV, and V
(Cortopassi and Arnheim 1990; Krishnan et al. 2007; Meissner
et al. 2008). In the present study, we adapted ddMDM tomultiplex
MT-ND4, a gene lyingwithin the deletion, and theD-Loop, a region
present in all replication-competent mtDNA molecules, such that
the proportion of mtDNA molecules carrying the 4977-bp com-
mon deletion can be calculated as 1 – MT-ND4/D-Loop. Primer
and probe sequences are listed in Supplemental Material.
As expected, stimulated PBMCs from young adults displayed
a significantly lower prevalence of the “mtDNA common dele-
tion” as compared to both old (aged 73±6) and frail centenarians
(Fig. 4C; Supplemental Table S4). Further, when we performed a
linear regression correlating the percentage of mtDNA molecules
carrying the common deletion with age in young, old, and frail
centenarians, we observed a significant age-related decrease in
the percentage of intact (unmutated) mtDNA (R2 =0.140; P=
0.006) (Fig. 4D; Supplemental Table S4). In addition, we found
no significant difference between young adults and healthy cente-
narians (Fig. 4C; Supplemental Table S4), andwhenwe substituted
healthy centenarians for frail centenarians and performed the
same linear regression, we no longer observed a significant correla-
tion (R2 = 0.003; P=0.257) (Fig. 4D; Supplemental Table S4).
Together, these data can be interpreted to show that mtDNA dele-
tions not only accumulate during aging but also that retaining
more intactmtDNA appears to be a feature of healthy centenarians
and healthy aging. Future investigations are required to explore
whether the ability to sustain a higher pool of unmutated
mtDNA is a consequence of good health and a relatively disease-
free status or whether it promotes optimal health status and it is
perhaps causal in some centenarians’ ability to maintain health
into extreme age.
Discussion
The growing number of epidemiological studies exploring the role
of mtDNA in health and disease showcases the need for more sen-
sitive and more efficient methods for mtDNA copy number quan-
tification. qPCR is still a major method in the field of mtDNA
biologyand, as a result,mtDNAcopynumbermeasurements are of-
ten confounded by a lack of absolute quantification. The relative
quantifications employed by most mtDNA investigations make
comparisons between different studies difficult to interpret and
presenthurdles to understanding the roles ofmtDNAcopynumber
variation during aging and disease onset and progression. This is at
least in part due to the following: (1) the differing PCR amplifica-
tion efficiency between the mtDNA target and housekeeping
genes, leading to altered mtDNA/nDNA ratios (Chen et al. 2007;
Regier and Frey 2010); and (2) themanner inwhichDNA is isolated
(Andreu et al. 2009; Malik et al. 2011). For example, DNA purified
by the manual phenol method can give randomly false high
mtDNA copy number values, while other column-based methods
seem to be less variable (Andreu et al. 2009). However, since
mtDNA is relatively small and exhibits different conformational
structures (e.g., supercoiled, relaxed, or linear), it can be lost more
easily than genomic DNA during DNA isolation, and different
methods lead to different mtDNA/nDNA ratios (Chen et al. 2007).
By developing ddMDM,wewere able to directly address these
key limitations. In particular, the direct use of cell lysates foregoes
the need of DNA purification and the complications described
above, while mtDNA quantitation based on cell equivalents per
the reaction eliminates the risk associated with differing PCR effi-
ciencies between mtDNA and nuclear reference genes. This also
has a critical upside in preventing biased results due to copy num-
ber variants of nuclear reference genes, which occur frequently in
cancer. Results are presented as D-Loop molecules per cell equiva-
lent, corresponding to number of mtDNA molecules per cell.
ddMDM further provides the added benefit of reduced costs and
workflow time and increased sensitivity to detect subtle alterations
in mtDNA levels. This could be particularly important for studies
aimed at investigating disease etiology and pathogenesis. For
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example, with this improved method, we were able to document,
in an in vitro model of human colorectal cancer, that upon cancer
initiation and early progression there is a slight but significant pro-
gressive decrease in mtDNA cellular content that correlates with
phenotypic changes (Fig. 3C; Supplemental Table S3). This
strengthens the hypothesis that metabolic reprograming is one
of the key hallmarks during cancer progression (Ward and
Thompson2012) and that lower levels ofmtDNA incertain cancers
may reflect a more stem-like metabolic program (Lee et al. 2015;
Menendez 2015). In addition, ddMDMallows formtDNAquantifi-
cations in single cells,whichwasnotpossibleusing theothermeth-
ods andmay be important for future investigations of mtDNA and
metabolic control at the single-cell level to better understand the
complex heterogeneity and dynamic landscape predicated upon
both cell autonomous and microenvironment features.
Our method also can be useful for epidemiologic studies
which are often characterized byminor variations inmtDNA levels
that are difficult to detect and often produce conflicting results
across different investigations. For example, we observed a mild
gradual age-related reduction inmtDNA copy number in stimulat-
ed PBMCs from a well-characterized human population aged 23–
113. However, healthy centenarians appeared to retain signifi-
cantly more mtDNA molecules and less major mtDNA deletions
(Fig. 4B–D; Supplemental Table S4). We have recently identified
and validated a number of genes involved in promoting immune
cell stimulation (e.g., CD28) and anti-inflammatory pathways
(e.g., IL10) whose expressions were significantly up-regulated in
healthy centenarians (Tedone et al. 2019) and thus positively cor-
relate with their increased mtDNA levels (Fig. 4B; Supplemental
Table S4). We also identified a number of genes involved in detri-
mental cellular processes such as apoptosis (e.g., BAX, PDCD1) and
chronic inflammation (e.g., TNF, IL1A, NLRP3) that were signifi-
cantly down-regulated in healthy centenarians (Tedone et al.
2019) and negatively correlate with mtDNA levels (Fig. 4B;
Supplemental Table S4). Overall, this suggests that retaining
more mtDNA copies (and with more efficient maintenance) dur-
ing immune cell stimulation and proliferation is a hallmark of
healthy centenarians and going forward, mtDNA quantitation
could be employed as a potential biomarker of healthy aging and
as a monitoring biomarker of mitochondrial dysfunction.
There is an increasing need to establish clinical reference
ranges ofmtDNA copy number in blood to be used in clinical diag-
nosis and monitoring of mitochondrial diseases as well as other
conditions. In this regard, new methods to directly estimate
mtDNA copy number from whole-genome sequencing data have
been recently developed (Ding et al. 2015; Cohen et al. 2016;
Qian et al. 2017). Thesemethods are based on the rationale that se-
quencing coverage should be proportional to the underlying DNA
copy number for autosomal and mitochondrial DNA. Although
mtDNA quantification through whole-genome sequencing data
analysis requires complex computation and considerably higher
costs, similarly to our method it provides absolute (not relative)
measurement of mtDNA copy number (Ding et al. 2015; Cohen
et al. 2016; Qian et al. 2017). These studies showed mtDNA copy
number in resting blood immune cells to range between 50 and
around 800 (Ding et al. 2015; Cohen et al. 2016), and this is in
line with our quantitations by using ddMDM (Fig. 4B, [day 0];
Supplemental Table S4).
In summary, we propose ddMDMas a novel high-throughput
and rapid (3 h) method that provides highly quantitative and sen-
sitive mtDNA measurements. ddMDMmay be useful for epidemi-
ologic studies, clinical monitoring of mitochondrial diseases, and
formuch needed studies aimed at better understanding the contri-
bution thatmtDNA plays in aging and disease, not only for its role
in metabolism but also as a signaling molecule. In fact, even
though the basis of anymechanism regulatingmtDNA copy num-
ber remains a poorly understood phenomenon (Gammage and
Frezza 2019), cellular mitochondrial content is believed to modu-
late global transcription (Guantes et al. 2015), but this is an area of
interest that remains mostly unexplored.
Methods
Cell culture
Human PBMCs were obtained from 61 donors in accordance with
the Institutional Review Board (IRB)-approved protocol (certifica-
tion number STU 042014-016) (Tedone et al. 2019). Subjects af-
fected by cancer, infections, or autoimmune diseases or on
immunosuppressive treatment at the time of enrollment were ex-
cluded from the study. The participant’s age at time of enrollment
was defined by birth certificates or identity documents. A trained
multidisciplinary staff collected from the enrolled volunteers in-
formation regarding their health status together with past and cur-
rent disease history. Venous blood samples were drawn from the
participants under fasting conditions at the same time in the
morning. The study protocol was approved by the Ethical Com-
mittee of Saint Orsola - Malpighi University Hospital (Bologna, It-
aly), and written informed consent was obtained from all subjects
in accordance with the International Declaration of Helsinki.
PBMCswere isolated by a density gradient centrifugationpro-
cedure as previously described (Tedone et al. 2015) and were then
cryopreserved at −140°C pending analysis. Cells were thawed 24 h
prior to stimulation and cultured in RPMI+GlutaMAX-I with 10%
fetal bovine serum, 1% penicillin, streptomycin, and Amphoteri-
cin B (Gemini Bio-Products). After 24 h, the cell suspensions
were transferred into a new flask to remove monocytes that tend
to adhere to the plastic and can phagocytose Dynabeads used for
T cell stimulation. PBMCs were stimulated by adding Dynabeads
Human T-Activator CD3/CD28 (Life Technologies) in a 1:1 cell-
to-bead ratio. After 72 h of stimulation, Dynabeads were removed
using a magnet and cells were cultured for up to 15 d after stimu-
lation. The percentage of live cells was determined every day by
trypan blue exclusion using a TC20 Automated Cell Counter
(Bio-Rad). Cell density was maintained at 1.0 × 106 cells/mL.
Jurkat (T leukemia) cells were cultured in RPMI+GlutaMAX-I
with 10% fetal bovine serum, 1% penicillin, streptomycin, and
Amphotericin B (Gemini Bio-Products) and maintained at 1.0 ×
106 cells/mL. H1299 (nonsmall cell lung adenocarcinoma), 293T
(human embryonic kidney), RPE (retinal pigment epithelial),
and various populations of normal human BJ (foreskin fibroblasts)
cells were cultured in ambient oxygen, 5% CO2, and maintained
in a 4:1 ratio of DMEM (Dulbecco’s Modified Eagle’s Medium,
GE Healthcare) to Medium 199 containing 10% calf serum
(HyClone). For quantification of mtDNA copy number at different
phases of the cell cycle (Supplemental Fig. 1D; Supplemental
Table S5), H1299 cells were blocked in G1/S phase by treating
with 2.5 mM thymidine for 16 h. Cells were then washed four
times with PBS and cultured for 8 h. Finally, cells were blocked
again with 2.5 mM thymidine for 16 h, washed four times with
PBS and then cultured as described above.
PrimaryHBECs were grown in 2% oxygen using a 1:1mixture
of bronchial epithelial basal medium (BEBM, Lonza) and DMEM
and supplemented with SingleQuot (Lonza) and 1% PSA.
Primary dermal foreskin fibroblasts (early passage BJ fibroblasts)
were isolated and cultured as previously described (Ramirez et al.
2003).
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The HCEC cancer progression series lines (1CT, 1CTP, 1CTR,
1CTRPA, 1CTRPM) were grown as described above. Initially, dip-
loid HCECs lines were established by TERT (T) and CDK4 (C) im-
mortalization. Then, additional lines bearing combinations of
commonly found mutations during colorectal cancer initiation
and early development were established. (A: APC shRNA stable
knockdown and truncated APC A1309 overexpression; M: MYC
overexpression; P: TP53 shRNA stable knockdown; R: mutant
KRASv12 overexpression) (Eskiocak et al. 2011; Zhang et al. 2015).
Cell lysis procedure for mtDNA quantification
Pellets containing 1 ×105 cells were collected and stored at −80°C
pending analysis. Cell pellets were lysed on ice using 40 µL of NP-
40 lysis buffer (10 mM Tris-HCl, pH 8.0, 1 mM MgCl2, 1 mM
EDTA, 1% [vol/vol] NP-40, 0.25 mM sodium deoxycholate, 10%
[vol/vol] glycerol, 150 mM NaCl, 5 mM β-mercaptoethanol, 0.1
mMAEBSF [4-(2-aminoethyl)benzenesulfonyl fluoride hydrochlo-
ride]) and vortexed every 15 min for a total of 45 min. Once lysed,
10 µL of lysate (containing 2.5 ×104 cell equivalents)were added to
9 µL of TNES buffer (10 mM Tris pH 8.0, 100 mM NaCl, 10 mM
EDTA, 1% SDS) and 1 µL of Proteinase K (20 mg/mL, Invitrogen).
Proteinase K digestion was performed at 50°C for 15min, followed
by 100°C for 10 min, then cooled to 12°C. Following Proteinase
K treatment, samples were diluted with ddH2O 1:250 to obtain
the final concentration of 5 cell equivalents per µL. After dilution,
samples were prepared for ddPCR. ddPCR is sensitive to oversatura-
tion of template molecules, and optimal sample dilution will vary
between cell types, dependent on mtDNA content per cell.
ddPCR by using cell lysates (ddMDM)
Each 20-µL ddPCR reaction contained a final concentration of 1×
EvaGreen ddPCR Supermix (Bio-Rad), 100 nM D-Loop forward,
100 nMD-Loop reverse primer, and 1 µL of sample (1–5 cell equiv-
alents, depending on cell line). Samples were partitioned into
droplets using a QX100 droplet generator (Bio-Rad) according to
the manufacturer’s instructions, and the emulsions (∼40 µL)
were transferred to a 96-well PCR plate (twin-tec, Eppendorf) and
sealed with foil (Thermo Fisher Scientific, AB0757). Following
droplet formation, PCRwas performed at 95°C for 5min, 40 cycles
of 95°C, 54°C, and 72°C for 30 sec each, then held at 12°C. The
ramp rate between all steps was 2.5°C/sec. After PCR, fluorescence
was measured using a QX100 droplet reader (Bio-Rad), detecting,
on average, 15,000–20,000 droplets per sample. The threshold
for positive droplets was determined by the software’s analysis of
droplet clustering across all samples and confirmed manually by
comparison to a negative, cell-free control (Fig. 1F; Supplemental
Table S1). The final output given by the software was a concentra-
tion of starting template molecules per µL and could be converted
tomolecules per 20-µL reaction (the original pre-emulsion volume
containing 1–5 cell equivalents). Finally, mtDNA per reaction was
normalized to obtain copies of mtDNA per cell equivalent
(ddMDM) (Fig. 1G; Supplemental Table S1).
For quantifications of mtDNA, expressed as molecules of
mtDNA per single-copy nuclear gene (D-Loop/NCOA3 ratio), two
reactions per sample were prepared: one containing 100 nM D-
Loop primers, the other containing 100 nM NCOA3 primers.
After PCR, the number of mtDNA copies per diploid genome was
calculated as previously described (Bai and Wong 2005).
Total genomic DNA extraction
Extraction and purification of total genomic DNA was performed
as previously described (D’Souza et al. 2007). Briefly, 2 × 105 cells
were pelleted and resuspended in 250 µL of SDS lysis buffer.
Samples were briefly vortexed then boiled for 10 min. Samples
were cooled to room temperature and treated with 2.5 µL of
RNase A (10 mg/mL, Qiagen) at 37°C for 2 h. Next, 2.5 µL of
Proteinase K (10 mg/mL) was added, and samples were incubated
at 55°C overnight. The next day, samples were boiled for 10 min,
followed by DNA precipitation by adding 0.1 volumes of 3 M
sodium acetate and 2 volumes of 100% ethanol at −20°C over-
night. Centrifugation was performed at 4°C at 1500g for 15 min.
Pellets were washed once in 70% ethanol and resuspended in
50 µL ddH20. DNA concentration of samples was measured by
a Qubit High Sensitivity DNA kit (Thermo Fisher Scientific).
ddPCR by using purified genomic DNA
mtDNA measurements from genomic DNA by using ddPCR were
performed as described (Wachsmuth et al. 2016). Briefly, total ge-
nomic DNA was isolated and ddPCR was performed as described
above. Absolute mtDNA copies per ddPCR reaction were normal-
ized to the single-copy nuclear gene NCOA3. In order to generate
a dilution curve for normalized results, mtDNA was measured in
serial dilutions of total genomic DNA and then normalized to
the nDNA measured from 0.1 ng of the same DNA.
qPCR
All qPCR reactions were performed as previously described (Bai
and Wong 2005) and consisted of 1 µL of sample (1 ng total
DNA), 1× Ssofast EvaGreen Supermix (Bio-Rad), 500 nM forward,
and 500 nM reverse primer to a final volume of 20 µL. qPCR was
performed using a LightCycler 480 (Roche) at 95°C for 5 min, 40
cycles of 95°C for 15 sec and 60°C for 60 sec, followed by melting
curve analysis. Samplesmeasured in qPCR represent the average of
three technical replicates, unless otherwise indicated. In order to
convert threshold cycles to absolute molecules, standard curves
of known amounts of purified D-Loop and NCOA3 amplicons
were run concurrently with qPCR samples. Exponential regres-
sions created from these standard curves were then used to calcu-
late mtDNA and nDNA per ng of DNA employed. Dilution
curves of normalized results were calculated as described above.
Preparation of purified amplicons
One nuclear and three mitochondrial primer pairs were chosen,
targeting NCOA3 (Bai and Wong 2005), the D-Loop region (Bai
and Wong 2005), MT-ND1 (Kim et al. 2013), and MT-TL1 (Bai
andWong 2005). These primers (sequences listed in Supplemental
Material) were confirmed for specificity by both agarose gel and by
qPCR melting curve analysis. PCR amplicons of these four primer
pairs were then purified from 1% agarose gels using a Qiagen Gel
Extraction kit, and concentrations were measured with a Qubit
High Sensitivity DNA kit (Thermo Fisher Scientific). Each ampli-
con was then diluted to 1× 109 molecules per µL, aliquoted, and
stored at −20°C.
Single-cell mtDNA quantification
Forty-eight hours prior to collection, cells were cultured at low
density in order to avoid potential contact-induced inhibition at
the single-cell level. After trypsinization, PBS was added to adjust
the cell density to ∼1×106 cells/mL; 1 ×105 cell pellets were col-
lected to be simultaneously run alongside single-cell samples as
pooled control samples. Single-cell isolation was performed as de-
scribed previously (Huang et al. 2017). In brief, cells were diluted in
1× PBS+0.1% FBS to 2000 cells/mL, and 1-µL aliquots were placed
on a glass slide. Drops containing exactly one single cell were iden-
tified under the microscope, and then each visually confirmed
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1-µL aliquot was transferred to a PCR tube containing 0.05 µL
Proteinase K (25 mg/mL, 1.25 µg final), 0.45 µL TNES buffer,
1 µL NP-40 lysis buffer (see above), and 7.5 µL MS2 RNA in
ddH2O (32 pg/µL, 240 pg final). MS2 RNAhelped to prevent exces-
sive quantities of DNA from sticking to tubes during single-cell re-
actions. The final 10-µL reactionwas run in a thermocycler at 50°C
for 30 min, 100°C for 10 min, then cooled to 12°C for lysis and
Proteinase K treatment. Fifteen microliters of ddH2O were then
added and the samplemixed thoroughly by pipetting; 7.5 µL of di-
luted sample (corresponding to 0.3 cell equivalents) was then used
to performddPCR reactions as described above,with the exception
of differing sample volumes. All single-cell ddMDM reactions
shown were run in triplicate.
Alternatively, single cells can be isolated by FACS so that
each cell will be automatically placed in a separate well of a
96-well PCR plate containing 0.05 µL Proteinase K (25 mg/mL,
1.25 µg final), 0.45 µL TNES buffer, 1 µL NP-40 lysis buffer (see
above), and 8.5 µL MS2 RNA in ddH2O (28.2 pg/µL, 240 pg final).
After this step, mtDNA quantification can be performed as de-
scribed above. However, we noted that single-cell isolation via
FACS often produced “false negative” (mtDNA copy number in
single cells resulted to be zero). This likely occurred due to the sort-
er not aliquoting a cell in the well or the cell was not directly ali-
quoted into the lysis buffer at the bottom of the well (these
results were excluded).
Therefore, we suggest employing the “operator performed”
single-cell isolation as described above and by Huang et al. (2017).
Statistical analysis
Statistical analyses were performed using Student’s t-test (un-
paired, two-tailed), ANOVA (Tukey’smultiple comparisons), or lin-
ear regression where appropriate. Significance was denoted as
follows: (∗) P≤0.05; (∗∗) P≤0.01; (∗∗∗) P≤0.001.
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